ARTICLE | Clinical News
Bexsero regulatory update
March 17, 2014 7:00 AM UTC
Novartis said that the Australian Technical Advisory Group on Immunisation (ATAGI) recommended the use of Bexero to vaccinate children ages <=2 years and adolescents ages 15-19 years against meningiti...